Top-News
Biotechnologie USA

Clearside Biomedical News

Aktie
WKN:  A2ALP6 ISIN:  US1850631045 US-Symbol:  CLSD
1,19 €
+0,03 €
+2,59%
20.05.24 08:11:50
Handeln Depot/Watchlist
Aktienanzahl *
62,41 Mio.
Marktkapitalisierung *
75,22 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 16.01.2024

Clearside Biomedical News

13.03.24 - PR Newswire
Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences?
Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences? PR Newswire
17.11.22 - PR Newswire
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical?
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire
10.11.22 - PR Newswire
Thinking about buying stock in Digital Turbine, Purple Innovation, Clearside Biomedical, Rivian Automotive, or ZipRecruiter?
Thinking about buying stock in Digital Turbine, Purple Innovation, Clearside Biomedical, Rivian Automotive, or ZipRecruiter? PR Newswire
28.03.22 - PR Newswire
Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners?
Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners? PR Newswire
11.03.22 - PR Newswire
Thinking about buying stock in Clearside Biomedical, Pearson, Paramount Gold Nevada, Hycroft Mining, or Alto Ingredients?
Thinking about buying stock in Clearside Biomedical, Pearson, Paramount Gold Nevada, Hycroft Mining, or Alto Ingredients? PR Newswire
25.10.21 - PR Newswire
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular ...
15.08.21 - PR Newswire
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India PR Newswire
25.06.21 - PR Newswire
Thinking about buying stock in Osmotica Pharmaceuticals, Property Solutions Acquisition, Sio Gene Therapies, Clearside Biomedical, or Sorrento Therapeutics?
Thinking about buying stock in Osmotica Pharmaceuticals, Property Solutions Acquisition, Sio Gene Therapies, Clearside Biomedical, or Sorrento Therapeutics? PR Newswire
17.06.21 - PR Newswire
Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals?
Thinking about buying stock in Clearside Biomedical, Acorda Therapeutics, Orphazyme, Nano-X Imaging, or Satsuma Pharmaceuticals? PR Newswire
02.06.21 - PR Newswire
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension)
Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) PR Newswire
08.01.21 - PR Newswire
Thinking about buying stock in Capricor Therapeutics, Cardtronics, Clearside Biomedical, Ardelyx, or FuelCell Energy?
Thinking about buying stock in Capricor Therapeutics, Cardtronics, Clearside Biomedical, Ardelyx, or FuelCell Energy? PR Newswire
05.01.21 - PR Newswire
Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology?
Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology? PR Newswire
04.01.21 - PR Newswire
Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray?
Thinking about buying stock in Ocugen, BioNano Genomics, FLIR Systems, Clearside Biomedical, or Viewray? PR Newswire
28.01.20 - PR Newswire
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in ...
17.12.19 - sharedeals.de
Clearside Biomedical: NBC-Aktie mit +307% in drei Monaten
Mit der Aktie von Clearside Biomedical (WKN: A2ALP6) nutzten NBC-​Mitglieder bereits Anfang des Jahres ordentliche Kurs­gewinne zum Ausstieg. Nach einer erneuten Empfehlung ...
17.12.19 - Finanztrends
Clearside Biomedical: NBC-Aktie mit +307% in drei Monaten
Mit der Aktie von Clearside Biomedical (WKN: A2ALP6) nutzten NBC-​Mitglieder bereits Anfang des Jahres ordentliche Kurs­gewinne zum Ausstieg. Nach einer erneuten Empfehlung ...
23.10.19 - PR Newswire
Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema ...
04.09.19 - PR Newswire
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314 - REGENXBIO ...
21.02.19 - PR Newswire
Thinking about buying stock in ARCA biopharma, Clearside Biomedical, Kandi Technologies, Nike or Tahoe Resources?
Thinking about buying stock in ARCA biopharma, Clearside Biomedical, Kandi Technologies, Nike or Tahoe Resources? PR Newswire
15.02.19 - sharedeals.de
Clearside: +47% nach weiterer Volltreffer-Ansage im NBC
Nach Kursgewinnen von teilweise mehr als +300% innerhalb kürzester Zeit reißen die Volltreffer-​Ansagen im NBC nicht ab. Mit Clearside Biomedical (WKN: A2ALP6) ist zuletzt ein ...

Newssuche

Videos

newspaper
17.05.24 +6,63%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »